Sign In
Buy UTHR
$549.47
+9.42 (+1.74%)
At Close: Jun 03, 2026
Christopher Patusky Sells 1,000 Shares of United Therapeutics (NASDAQ:UTHR) Stock
04:36am, Sunday, 19'th Apr 2026
United Therapeutics Corporation (NASDAQ: UTHR - Get Free Report) Director Christopher Patusky sold 1,000 shares of the business's stock in a transaction that occurred on Friday, April 17th. The shares
United Therapeutics (NASDAQ:UTHR) EVP Sells $4,787,606.00 in Stock
04:05am, Sunday, 19'th Apr 2026
United Therapeutics Corporation (NASDAQ: UTHR - Get Free Report) EVP Paul Mahon sold 8,300 shares of the stock in a transaction that occurred on Thursday, April 16th. The stock was sold at an average
Insider Selling: United Therapeutics (NASDAQ:UTHR) CEO Sells $5,513,420.00 in Stock
04:05am, Sunday, 19'th Apr 2026
United Therapeutics Corporation (NASDAQ: UTHR - Get Free Report) CEO Martine Rothblatt sold 9,500 shares of the firm's stock in a transaction that occurred on Wednesday, April 15th. The stock was sold
James Edgemond Sells 10,000 Shares of United Therapeutics (NASDAQ:UTHR) Stock
04:05am, Sunday, 19'th Apr 2026
United Therapeutics Corporation (NASDAQ: UTHR - Get Free Report) CFO James Edgemond sold 10,000 shares of the business's stock in a transaction that occurred on Thursday, April 16th. The stock was sol
United Therapeutics Target of Unusually High Options Trading (NASDAQ:UTHR)
01:00am, Saturday, 18'th Apr 2026
United Therapeutics Corporation (NASDAQ: UTHR - Get Free Report) was the target of unusually large options trading activity on Friday. Stock investors bought 15,930 call options on the company. This r
James Edgemond Sells 10,000 Shares of United Therapeutics (NASDAQ:UTHR) Stock
04:05am, Thursday, 16'th Apr 2026
United Therapeutics Corporation (NASDAQ: UTHR - Get Free Report) CFO James Edgemond sold 10,000 shares of the company's stock in a transaction on Monday, April 13th. The shares were sold at an average
Martine Rothblatt Sells 9,500 Shares of United Therapeutics (NASDAQ:UTHR) Stock
04:05am, Thursday, 16'th Apr 2026
United Therapeutics Corporation (NASDAQ: UTHR - Get Free Report) CEO Martine Rothblatt sold 9,500 shares of the firm's stock in a transaction that occurred on Monday, April 13th. The shares were sold
United Therapeutics (NASDAQ:UTHR) CEO Martine Rothblatt Sells 9,500 Shares
04:11am, Tuesday, 14'th Apr 2026
United Therapeutics Corporation (NASDAQ: UTHR - Get Free Report) CEO Martine Rothblatt sold 9,500 shares of the business's stock in a transaction dated Friday, April 10th. The shares were sold at an a
James Edgemond Sells 10,000 Shares of United Therapeutics (NASDAQ:UTHR) Stock
04:19am, Sunday, 12'th Apr 2026
United Therapeutics Corporation (NASDAQ: UTHR - Get Free Report) CFO James Edgemond sold 10,000 shares of the firm's stock in a transaction dated Thursday, April 9th. The shares were sold at an averag
Martine Rothblatt Sells 9,500 Shares of United Therapeutics (NASDAQ:UTHR) Stock
04:16am, Saturday, 11'th Apr 2026
United Therapeutics Corporation (NASDAQ: UTHR - Get Free Report) CEO Martine Rothblatt sold 9,500 shares of the stock in a transaction that occurred on Wednesday, April 8th. The stock was sold at an a
Pre-Market Stock Futures: The futures are trading mixed as we approach the end of one of the most volatile and wild trading weeks in recent memory. After starting the day lower on Thursday as mixed re
Martine Rothblatt Sells 9,500 Shares of United Therapeutics (NASDAQ:UTHR) Stock
04:03am, Thursday, 09'th Apr 2026
United Therapeutics Corporation (NASDAQ: UTHR - Get Free Report) CEO Martine Rothblatt sold 9,500 shares of the firm's stock in a transaction that occurred on Monday, April 6th. The stock was sold at
James Edgemond Sells 10,000 Shares of United Therapeutics (NASDAQ:UTHR) Stock
04:03am, Thursday, 09'th Apr 2026
United Therapeutics Corporation (NASDAQ: UTHR - Get Free Report) CFO James Edgemond sold 10,000 shares of United Therapeutics stock in a transaction on Monday, April 6th. The shares were sold at an av
United Therapeutics Receives FDA Regenerative Medicine Advanced Therapy Designation for miroliverELAP® for Treatment of Acute Liver Failure
07:00am, Wednesday, 08'th Apr 2026
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that the U.S. Food and Drug Administra
Market Today: Oil Shock, Airline Moves, UMG Bid, LEVI Beat
05:33pm, Tuesday, 07'th Apr 2026
Guru Stock PicksBrandes Investment Partners, LP has made the following transactions:Add in KMT by 0.94%Stock News Stocks steady into Iran deadline: The S&P 500
